UK policy-makers face calls to better prioritise 3 million-case COPD (chronic obstructive pulmonary disease):
This article was originally published in Clinica
Executive Summary
The UK's chief medical officer and the British Lung Foundation are leading calls for a National Service Framework on Chronic Obstructive Pulmonary Disease (COPD). In the UK, the condition affects an estimated three million people and kills more than 33,000. The economic burden of the disease on the health services is estimated at more than £800m ($1.4bn) per year, with 84% of costs seen at secondary care. Effective management can, however, reduce the burden related to emergency hospitalisation and length of stay. The issue was raised in the UK parliament on November 23, through an early day motion, sponsored by Howard Stoate MP, asking the government to make COPD a priority.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.